Royal Bank Of Canada Organogenesis Holdings Inc. Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 74,778 shares of ORGO stock, worth $249,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,778
Previous 94,990
21.28%
Holding current value
$249,758
Previous $265,000
19.62%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ORGO
# of Institutions
118Shares Held
64.3MCall Options Held
25KPut Options Held
23.2K-
Morgan Stanley New York, NY12MShares$40 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT11.8MShares$39.5 Million2.88% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$17 Million0.0% of portfolio
-
Deutsche Bank Ag\ Frankfurt Am Main, 2M4.84MShares$16.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$12.3 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $437M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...